Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

George Pentheroudakis

ESMO Chief Medical Officer

pentheroudakis-george
Country

Switzerland

Address
ESMO Head Office, Lugano

George Pentheroudakis (born 3/12/1967) holds an MD degree from the Aristotle University of Thessaloniki, Greece (1991). He specialized in Internal Medicine in Thessaloniki, Greece (1993-1999). Subsequently he trained in Medical Oncology at the Beatson Oncology Centre, Glasgow, United Kingdom (1999-2002) where he gained experience in the development of Phase I-III clinical trials.

Returning to Greece, he developed his PhD thesis on mechanisms of neutrophil production of surface mucoglycoproteins from GCSF stimulation and successfully defended it in 2006. He worked as a Consultant Medical Oncologist at the Department of Medical Oncology, University of Ioannina, Greece, since 2003, serving as Chair of the Scientific Committee of the Hellenic Cooperative Oncology Group (HeCOG) from 2012 to 2016.

He is Professor of Oncology at the Medical School, University of Ioannina, Department of Medical Oncology since 2018, where he established a Translational and Clinical Research Unit, a Palliative and Supportive Care Unit and a Liquid Biopsy Unit. He spearheaded its admission to the EORTC GI Working Group, SAKK and its designation as ESMO Centre of Excellence for Integrated Oncology. He had regular teaching duties and was actively involved in translational research in cancer and in early phase I-II studies evaluating novel agents in collaboration with national and international groups. His main research interests are gastrointestinal cancer, cancer of unknown primary, translational cancer research.

Since August 2020, Professor Pentheroudakis serves as ESMO Chief Medical Officer, after having served as Guidelines Committee Chair (2016-2020), member of the Executive Board (2016-2018), ESMO CUP and Endocrine Tumour Faculty Coordinator. He is also a member of the American Society of Clinical Oncology (ASCO) and is actively involved in different medical journal editorial boards including Cancers, Cancer Treatment Communications, EJSO - European Journal of Surgical Oncology, Rare Cancers and Therapy, ESMO Open. He has (co)-authored 291 PubMed-indexed peer-reviewed papers and speaks English, French and Italian.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings